CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $40,016,521
- in 15 filings, $36.7M under 10b5-1 plans
Net −$40,016,521. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-12 | Alton Gregg H Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2020-02-26 | BELANOFF JOSEPH K Chief Executive Officer | Returned to the company | −20,338 | $13.54 | $275K | 2,499,214 |
| 2020-02-07 | Robb Gary Charles Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-02-07 | Maduck Sean See Remarks | Grant or award · Stock Option (Right to Buy) | +250,000 | 250,000 | ||
| 2020-02-07 | BELANOFF JOSEPH K Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2020-02-07 | Grauer Andreas Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2019-12-09 | Robb Gary Charles Chief Financial Officer | Option exercise | +30,000 | $1.92 | $58K | 38,025 |
| 2019-12-09 | Robb Gary Charles Chief Financial Officer | Sale | −30,000 | $13.73 | $412K | 8,025 |
| 2019-12-09 | Robb Gary Charles Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −30,000 | 45,000 | ||
| 2019-10-28 | WILSON JAMES N Director | Option exercise | +284,218 | $2.30 | $654K | 400,000 |
| 2019-10-28 | WILSON JAMES N Director | Shares withheld for taxes | −153,712 | $14.63 | $2.2M | 246,288 |
| 2019-10-28 | WILSON JAMES N Director | Option exercise · Stock Option (Right to Buy) | −284,218 | 0 | ||
| 2019-10-28 | WILSON JAMES N Director | Option exercise | +284,218 | $2.30 | $654K | 400,000 |
| 2019-10-28 | WILSON JAMES N Director | Shares withheld for taxes | −153,754 | $14.63 | $2.2M | 246,246 |
| 2019-10-28 | WILSON JAMES N Director | Option exercise · Stock Option (Right to Buy) | −284,218 | 0 | ||
| 2019-09-17 | Park Kimberly Director | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2019-06-18 | Swisher Daniel N JR Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-06-18 | WILSON JAMES N Director | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2019-06-18 | MAHONEY DAVID L Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2019-06-18 | BAKER G LEONARD JR Director | Grant or award · Stock Option (Right To Buy) | +25,000 | 25,000 |
Page 66 of 72 · 1,435 trades